Clinical Trial Update: Lenalidomide, Fludarabine & Cyclophosphamide in Advanced Chronic Lymphocytic Leukemia Not Responding to Therapy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial of lenalidomide in combination with fludarabine and cyclophosphamide for advanced chronic lymphocytic leukemia not responding to prior …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Chronic Lymphocytic Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-01-22